...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: 47 Taken out by Gilead for $4.9 billion

What I find truly stunning about the purchase of FTSV is that on October 23 2019, its share price was only $5.53, giving it a market cap of about US$300 million.  It is being bought out for $95.5 cash at $4.5 billion. 

Now FTSV is in cancer research.  We are in CVD of course.  Not apples to apples...but surely, someone can give us $2 billion in cash?

Icon

Share
New Message
Please login to post a reply